Audiological and electrophysiological alterations in HIV-infected individuals subjected or not to antiretroviral therapy

被引:5
|
作者
Matas, Carla Gentile [1 ]
Samelli, Alessandra Giannella [1 ]
Leite Magliaro, Fernanda Cristina [1 ]
Segurado, Aluisio [2 ]
机构
[1] Univ Sao Paulo, Fac Med, Dept Fisioterapia Fonoaudiol & Terapia Ocupac, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Acquired immunodeficiency syndrome; Adults; Auditory evoked potentials; Hearing loss; HIV; HUMAN-IMMUNODEFICIENCY-VIRUS; HEARING-LOSS; AIDS; MANIFESTATIONS; OTOTOXICITY; IMPAIRMENT; POTENTIALS; DISEASE;
D O I
10.1016/j.bjorl.2017.07.003
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: The Human Immunodeficiency Virus (HIV) and infections related to it can affect multiple sites in the hearing system. The use of High Activity Anti-Retroviral Therapy (HAART) can cause side effects such as ototoxicity. Thus, no consistent patterns of hearing impairment in adults with Human Immunodeficiency Virus / Acquired Immune Deficiency Syndrome have been established, and the problems that affect the hearing system of this population warrant further research. Objectives: This study aimed to compare the audiological and electrophysiological data of Human Immunodeficiency Virus-positive patients with and without Acquired Immune Deficiency Syndrome, who were receiving High Activity Anti-Retroviral Therapy, to healthy individuals. Methods: It was a cross-sectional study conducted with 71 subjects (30-48 years old), divided into groups: Research Group I: 16 Human Immunodeficiency Virus-positive individuals without Acquired Immunodeficiency Syndrome (not receiving antiretroviral treatment); Research Group II: 25 Human Immunodeficiency Virus-positive individuals with Acquired Immunodeficiency Syndrome (receiving antiretroviral treatment); Control Group: 30 healthy subjects. All individuals were tested by pure-tone air conduction thresholds at 0.25-8 kHz, extended high frequencies at 9-20 kHz, electrophysiological tests (Auditory Brainstem Response, Middle Latency Responses, Cognitive Potential). Results: Research Group I and Research Group II had higher hearing thresholds in both conventional and high frequency audiometry when compared to the control group, prolonged latency of waves I, III, V and interpeak I-V in Auditory Brainstem Response and prolonged latency of P300 Cognitive Potential. Regarding Middle Latency Responses, there was a decrease in the amplitude of the Pa wave of Research Group II compared to the Research Group I. Conclusions: Both groups with Human Immunodeficiency Virus had higher hearing thresholds when compared to healthy individuals (group exposed to antiretroviral treatment showed the worst hearing threshold) and seemed to have lower neuroelectric transmission speed along the auditory pathway in the brainstem, subcortical and cortical regions. (C) 2018 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda.
引用
收藏
页码:574 / 582
页数:9
相关论文
共 50 条
  • [31] Antiretroviral therapy changes in HIV-infected children
    Purswani, MU
    Johann-Liang, R
    Cervia, JS
    Noel, GJ
    PEDIATRIC RESEARCH, 1999, 45 (04) : 171A - 171A
  • [32] Antiretroviral Therapy in HIV-Infected Infants and Children
    Maron, Gabriela
    Gaur, Aditya H.
    Flynn, Patricia M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (04) : 360 - 363
  • [33] Nephrotoxicity of antiretroviral therapy in an HIV-infected patient
    Said, S. M.
    Nasr, S. H.
    Samsa, R.
    Markowitz, G. S.
    D'Agati, V. D.
    KIDNEY INTERNATIONAL, 2007, 71 (10) : 1071 - 1075
  • [34] ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS - UPDATE
    BARTLETT, JG
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1994, 3 (05) : 340 - 344
  • [35] Antiretroviral therapy for pregnant HIV-infected women
    Luber, AD
    Dong, BJ
    ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 509 - 509
  • [36] Psoriasis in an HIV-Infected Woman on Antiretroviral Therapy
    Nwako-Mohamadi, Maitseo K.
    Madan, Vidushi
    Tanko, Matthew N.
    Vento, Sandro
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (04): : 262 - 263
  • [37] ANTIRETROVIRAL THERAPY IN ADULT HIV-INFECTED PATIENTS
    SALZBERGER, B
    SCHRAPPE, M
    DIEHL, V
    INTERNIST, 1994, 35 (12): : 1095 - 1104
  • [38] The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy
    Lau, Jillian S. Y.
    McMahon, James H.
    Gubser, Celine
    Solomon, Ajantha
    Chiu, Chris Y. H.
    Dantanarayana, Ashanti
    Chea, Socheata
    Tennakoon, Surekha
    Zerbato, Jennifer M.
    Garlick, Jill
    Morcilla, Vincent
    Palmer, Sarah
    Lewin, Sharon R.
    Rasmussen, Thomas A.
    AIDS, 2021, 35 (10) : 1631 - 1636
  • [39] Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals
    Tumbarello, M
    Tacconelli, E
    Bertagnolio, S
    Cauda, R
    AIDS, 2000, 14 (18) : 2948 - 2949
  • [40] Incidence and Timing of Cancer in HIV-Infected Individuals Following Initiation of Combination Antiretroviral Therapy
    Yanik, Elizabeth L.
    Napravnik, Sonia
    Cole, Stephen R.
    Achenbach, Chad J.
    Gopal, Satish
    Olshan, Andrew
    Dittmer, Dirk P.
    Kitahata, Mari M.
    Mugavero, Michael J.
    Saag, Michael
    Moore, Richard D.
    Mayer, Kenneth
    Mathews, W. Christopher
    Hunt, Peter W.
    Rodriguez, Benigno
    Eron, Joseph J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (05) : 756 - 764